Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GDRX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGDRXGoodRx$4.57+3.2%$4.76$4.09▼$9.26$1.75B1.251.37 million shs1.47 million shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGDRXGoodRx+0.45%-2.64%-11.04%-4.73%-37.61%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGDRXGoodRx3.6608 of 5 stars3.44.00.00.03.51.71.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGDRXGoodRx 2.80Moderate Buy$8.1878.88% UpsideCurrent Analyst Ratings BreakdownLatest GDRX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails2/28/2025GDRXGoodRxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$9.00 ➝ $8.001/10/2025GDRXGoodRxCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$7.00 ➝ $6.251/8/2025GDRXGoodRxKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$7.00 ➝ $6.00(Data available from 4/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGDRXGoodRx$792.32M2.21$0.39 per share11.77$1.93 per share2.37Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGDRXGoodRx-$8.87M$0.05N/A25.392.46-2.05%5.35%2.51%5/8/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGDRXGoodRxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGDRXGoodRx0.705.485.48Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGDRXGoodRx63.77%Insider OwnershipCompanyInsider OwnershipGDRXGoodRx4.17%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGDRXGoodRx950383.61 million365.25 millionOptionableGDRX HeadlinesRecent News About These CompaniesGoodRx Holdings, Inc. (NASDAQ:GDRX) Given Average Recommendation of "Moderate Buy" by AnalystsApril 2 at 2:30 AM | marketbeat.comRaymond James Financial Inc. Makes New $2.50 Million Investment in GoodRx Holdings, Inc. (NASDAQ:GDRX)March 30 at 3:16 AM | marketbeat.comCharles Schwab Investment Management Inc. Boosts Stock Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX)March 30 at 3:08 AM | marketbeat.comQuantbot Technologies LP Buys 91,111 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX)March 29, 2025 | marketbeat.comGoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its CapitalMarch 27, 2025 | uk.finance.yahoo.comGoodRx Joins NCPDP's Elite Partner Program, Demonstrating Long-Term Commitment to Advancing Healthcare StandardsMarch 25, 2025 | finance.yahoo.comGoodRx: Great Value For Patient Investors (Upgrade)March 24, 2025 | seekingalpha.comVictory Capital Management Inc. Has $568,000 Stock Position in GoodRx Holdings, Inc. (NASDAQ:GDRX)March 22, 2025 | marketbeat.comTocqueville Asset Management L.P. Takes $1.31 Million Position in GoodRx Holdings, Inc. (NASDAQ:GDRX)March 21, 2025 | marketbeat.comGoodRx (NASDAQ:GDRX) Shares Up 5.5% - Should You Buy?March 20, 2025 | marketbeat.comCounterpoint Mutual Funds LLC Purchases Shares of 156,439 GoodRx Holdings, Inc. (NASDAQ:GDRX)March 18, 2025 | marketbeat.comGoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical EngagementMarch 17, 2025 | finance.yahoo.comConnor Clark & Lunn Investment Management Ltd. Grows Position in GoodRx Holdings, Inc. (NASDAQ:GDRX)March 16, 2025 | marketbeat.comGoodRx Report Reveals Striking Gender Divide in Prescription Medication SpendingMarch 10, 2025 | tmcnet.comGoodRx Holdings, Inc. (GDRX): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock?March 10, 2025 | insidermonkey.comGoodRx Holdings, Inc. (GDRX): Among the Cash-Rich Small Cap Stocks To Invest In According To AnalystsMarch 7, 2025 | insidermonkey.comGoodRx Holdings, Inc. (GDRX): Among the Cash-Rich Small Cap Stocks To Invest In According To AnalystsMarch 7, 2025 | uk.finance.yahoo.comGoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Recommendation of "Moderate Buy" from BrokeragesMarch 7, 2025 | marketbeat.comThe Analyst Verdict: GoodRx Holdings In The Eyes Of 4 ExpertsMarch 2, 2025 | nasdaq.comTruist Financial Reaffirms Their Hold Rating on GoodRx Holdings (GDRX)March 1, 2025 | markets.businessinsider.comGoodRx Holdings (GDRX) Receives a Hold from Morgan StanleyMarch 1, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGDRX Company DescriptionsGoodRx NASDAQ:GDRX$4.57 +0.14 (+3.16%) Closing price 04:00 PM EasternExtended Trading$4.56 -0.01 (-0.20%) As of 04:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Analyst Targets Signal More Growth in CrowdStrike Stock NextEra Energy Stock Sees Spike in Bullish Call Activity 2 Reasons to Buy Apple Stock and 1 Significant Risk Salesforce: The Most Resilient Software Stock for Downturns D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy Boeing Stock Upgraded After Beating Lockheed for Jet Deal Amazon Falls Back to a Key Support Line: Here's How to Play It Why Howmet Could Be the Sleeper Aerospace Name of 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
